These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 15471887)

  • 1. Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway.
    Luiro K; Yliannala K; Ahtiainen L; Maunu H; Järvelä I; Kyttälä A; Jalanko A
    Hum Mol Genet; 2004 Dec; 13(23):3017-27. PubMed ID: 15471887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
    Uusi-Rauva K; Luiro K; Tanhuanpää K; Kopra O; Martín-Vasallo P; Kyttälä A; Jalanko A
    Exp Cell Res; 2008 Sep; 314(15):2895-905. PubMed ID: 18621045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevation of Hook1 in a disease model of Batten disease does not affect a novel interaction between Ankyrin G and Hook1.
    Weimer JM; Chattopadhyay S; Custer AW; Pearce DA
    Biochem Biophys Res Commun; 2005 May; 330(4):1176-81. PubMed ID: 15823567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuronal ceroid lipofuscinosis protein CLN3 interacts with motor proteins and modifies location of late endosomal compartments.
    Uusi-Rauva K; Kyttälä A; van der Kant R; Vesa J; Tanhuanpää K; Neefjes J; Olkkonen VM; Jalanko A
    Cell Mol Life Sci; 2012 Jun; 69(12):2075-89. PubMed ID: 22261744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisiting the neuronal localization and trafficking of CLN3 in juvenile neuronal ceroid lipofuscinosis.
    Oetjen S; Kuhl D; Hermey G
    J Neurochem; 2016 Nov; 139(3):456-470. PubMed ID: 27453211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A galactosylceramide binding domain is involved in trafficking of CLN3 from Golgi to rafts via recycling endosomes.
    Persaud-Sawin DA; McNamara JO; Rylova S; Vandongen A; Boustany RM
    Pediatr Res; 2004 Sep; 56(3):449-63. PubMed ID: 15240864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defective lysosomal arginine transport in juvenile Batten disease.
    Ramirez-Montealegre D; Pearce DA
    Hum Mol Genet; 2005 Dec; 14(23):3759-73. PubMed ID: 16251196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
    Chan CH; Mitchison HM; Pearce DA
    Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of Kv4.2/KChIP3 interaction by the ceroid lipofuscinosis neuronal 3 protein CLN3.
    Seifert C; Storch S; Bähring R
    J Biol Chem; 2020 Aug; 295(34):12099-12110. PubMed ID: 32641494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular mechanisms of the juvenile form of Batten disease: important role of MAPK signaling pathways (ERK1/ERK2, JNK and p38) in pathogenesis of the malady.
    Shematorova EK; Shpakovski DG; Chernysheva AD; Shpakovski GV
    Biol Direct; 2018 Sep; 13(1):19. PubMed ID: 30621751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
    Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
    J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular trafficking of the JNCL protein CLN3.
    Haskell RE; Derksen TA; Davidson BL
    Mol Genet Metab; 1999 Apr; 66(4):253-60. PubMed ID: 10191111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective intracellular transport of CLN3 is the molecular basis of Batten disease (JNCL).
    Järvelä I; Lehtovirta M; Tikkanen R; Kyttälä A; Jalanko A
    Hum Mol Genet; 1999 Jun; 8(6):1091-8. PubMed ID: 10332042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CLN3 deficient cells display defects in the ARF1-Cdc42 pathway and actin-dependent events.
    Schultz ML; Tecedor L; Stein CS; Stamnes MA; Davidson BL
    PLoS One; 2014; 9(5):e96647. PubMed ID: 24792215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CLN3, at the crossroads of endocytic trafficking.
    Cotman SL; Lefrancois S
    Neurosci Lett; 2021 Sep; 762():136117. PubMed ID: 34274435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deletion of the Caenorhabditis elegans homologues of the CLN3 gene, involved in human juvenile neuronal ceroid lipofuscinosis, causes a mild progeric phenotype.
    de Voer G; van der Bent P; Rodrigues AJ; van Ommen GJ; Peters DJ; Taschner PE
    J Inherit Metab Dis; 2005; 28(6):1065-80. PubMed ID: 16435200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: new clues to Batten disease.
    Luiro K; Kopra O; Lehtovirta M; Jalanko A
    Hum Mol Genet; 2001 Sep; 10(19):2123-31. PubMed ID: 11590129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
    Järvelä I; Sainio M; Rantamäki T; Olkkonen VM; Carpén O; Peltonen L; Jalanko A
    Hum Mol Genet; 1998 Jan; 7(1):85-90. PubMed ID: 9384607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel role of the Batten disease gene CLN3: association with BMP synthesis.
    Hobert JA; Dawson G
    Biochem Biophys Res Commun; 2007 Jun; 358(1):111-6. PubMed ID: 17482562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Btn2, a Hook1 ortholog and potential Batten disease-related protein, mediates late endosome-Golgi protein sorting in yeast.
    Kama R; Robinson M; Gerst JE
    Mol Cell Biol; 2007 Jan; 27(2):605-21. PubMed ID: 17101785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.